# Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

> **NCT04654988** · PHASE4 · RECRUITING · sponsor: **Medical University of Warsaw** · enrollment: 100 (estimated)

## Conditions studied

- Myocarditis
- Heart Failure
- Endomyocardial Biopsy
- Cardiomyopathies, Secondary
- Immunosuppression

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Azathioprine
- **DRUG:** Placebo Prednisone
- **DRUG:** Placebo Azathioprine

## Key facts

- **NCT ID:** NCT04654988
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-03-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654988, "Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04654988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*